Advanced Pharmacology – Midterm Verified Exam Questions and
Answers Latest update 2026/2027
Question:
1. Nurse practitioner prescriptive authority is regulated by:
a. The National Council of Sate Board of Nursing
b. The State Board of Nursing for each state
c. The U. S. Drug Enforcement Administration
d. The State Board of Pharmacy
Answer:
b. The State Board of
Nursing for each state
Question:
2. Eight Information needed for the prescription
Answer:
1. Date of prescribing;
2. Name of patient(s);
3. Prescriber's name;
4. Name, strength, and
dosage of drug or device;
5. Number of refills, if applicable;
6. Quantity prescribed in
weight, volume, or number of units;
7. An indication of whether
generic substitution has been authorized by the prescriber;
8. Any change or alteration
made to the prescription dispensed on contact with the prescriber must show a clear audit trail.
Question:
3. Three additional required information for controlled substances
Answer:
1. Address of the prescriber and patient;
2. The prescriber's DEA
number; 3 Controlled prescriptions shall also comply with all requirements of federal and state
controlled substance laws.
,Question:
4. Who oversees the APRN's prescribing of controlled substances?
a. The pharmaceutical board of the state
b. The federal government (DEA)
c. The practice protocols of the hospital
d. Practice agreements
Answer:
b. The federal government
(DEA)
Question:
5. The USFDA regulates:
a. Prescribing of drugs by medical doctors and nurse
practitioners
b. The official labeling for all prescription and
over-the-counter drugs
c. Off-label recommendations for prescribing
d. Pharmaceutical educational offering
Answer:
b. The oflcial labeling
for all prescription and over-the-counter drugs
Question:
6. Medication agreements or "Pain Medication Contracts" are recommended to be used:
a. Universally for all prescribing for chronic pain
b. For patients who have repeated requests for pain
medication
c. When you suspect a patient is exhibiting drug-seeking behavior
d. For patients with pain associated with malignancy
Answer:
a. Universally for all prescribing for chronic pain
, Question:
7.
Anaphylactic shock is a:
a. Type I reaction, called immediate hypersensitivity
reaction
b. Type II reaction, called cytotoxic hypersensitivity reaction
c. Type III reaction, called immune complex hypersensitivity
d. Type IV reaction, called delayed hypersensitivity reaction
Answer:
a. Type I reaction, called
immediate hypersensitivity reaction
Question:
8. The role of the nurse practitioner with regards to herbal medication is to:
a. Maintain competence in the prescribing of common
herbal remedies.
b. Recommend common over-the-counter herbs to patients.
c. Educate patients and guide them to appropriate
sources of care.
d. Encourage patients to not use herbal therapy due to
the documented dangers.
Answer:
c. Educate patients and
guide them to appropriate sources of care.
Question:
9. Prescribing for women during their childbearing years c. Possible unknown pregrequires constant
awareness of the possibility of:
a. High risk for developmental disorders in their infants
b. Decreased risk for abuse during this time
c. Possible unknown pregnancy
d. Possibility of drug allergies
Answer:
nancy
Answers Latest update 2026/2027
Question:
1. Nurse practitioner prescriptive authority is regulated by:
a. The National Council of Sate Board of Nursing
b. The State Board of Nursing for each state
c. The U. S. Drug Enforcement Administration
d. The State Board of Pharmacy
Answer:
b. The State Board of
Nursing for each state
Question:
2. Eight Information needed for the prescription
Answer:
1. Date of prescribing;
2. Name of patient(s);
3. Prescriber's name;
4. Name, strength, and
dosage of drug or device;
5. Number of refills, if applicable;
6. Quantity prescribed in
weight, volume, or number of units;
7. An indication of whether
generic substitution has been authorized by the prescriber;
8. Any change or alteration
made to the prescription dispensed on contact with the prescriber must show a clear audit trail.
Question:
3. Three additional required information for controlled substances
Answer:
1. Address of the prescriber and patient;
2. The prescriber's DEA
number; 3 Controlled prescriptions shall also comply with all requirements of federal and state
controlled substance laws.
,Question:
4. Who oversees the APRN's prescribing of controlled substances?
a. The pharmaceutical board of the state
b. The federal government (DEA)
c. The practice protocols of the hospital
d. Practice agreements
Answer:
b. The federal government
(DEA)
Question:
5. The USFDA regulates:
a. Prescribing of drugs by medical doctors and nurse
practitioners
b. The official labeling for all prescription and
over-the-counter drugs
c. Off-label recommendations for prescribing
d. Pharmaceutical educational offering
Answer:
b. The oflcial labeling
for all prescription and over-the-counter drugs
Question:
6. Medication agreements or "Pain Medication Contracts" are recommended to be used:
a. Universally for all prescribing for chronic pain
b. For patients who have repeated requests for pain
medication
c. When you suspect a patient is exhibiting drug-seeking behavior
d. For patients with pain associated with malignancy
Answer:
a. Universally for all prescribing for chronic pain
, Question:
7.
Anaphylactic shock is a:
a. Type I reaction, called immediate hypersensitivity
reaction
b. Type II reaction, called cytotoxic hypersensitivity reaction
c. Type III reaction, called immune complex hypersensitivity
d. Type IV reaction, called delayed hypersensitivity reaction
Answer:
a. Type I reaction, called
immediate hypersensitivity reaction
Question:
8. The role of the nurse practitioner with regards to herbal medication is to:
a. Maintain competence in the prescribing of common
herbal remedies.
b. Recommend common over-the-counter herbs to patients.
c. Educate patients and guide them to appropriate
sources of care.
d. Encourage patients to not use herbal therapy due to
the documented dangers.
Answer:
c. Educate patients and
guide them to appropriate sources of care.
Question:
9. Prescribing for women during their childbearing years c. Possible unknown pregrequires constant
awareness of the possibility of:
a. High risk for developmental disorders in their infants
b. Decreased risk for abuse during this time
c. Possible unknown pregnancy
d. Possibility of drug allergies
Answer:
nancy
